Healthcare resource utilization and costs associated with anogenital warts in Morocco

Abstract Background Human papillomavirus (HPV), primarily genotypes 6 and 11, cause the majority of cases of anogenital warts (AGW). Although benign, AGW are associated with a substantial economic and psychosocial burden. Several vaccines have been developed to prevent HPV. The objective of this stu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Myriam Berrada, Ryan Holl, Tidiane Ndao, Goran Benčina, Siham Dikhaye, Abdelilah Melhouf, Soumiya Chiheb, Khalid Guelzim
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Anogenital warts Genital warts Condyloma acuminatum Papillomavirus infections Epidemiology North Africa Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/6824c1857f884002b98fd070ff8214c6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6824c1857f884002b98fd070ff8214c6
record_format	dspace
spelling	oai:doaj.org-article:6824c1857f884002b98fd070ff8214c62021-11-21T12:09:22ZHealthcare resource utilization and costs associated with anogenital warts in Morocco10.1186/s13027-021-00403-11750-9378https://doaj.org/article/6824c1857f884002b98fd070ff8214c62021-11-01T00:00:00Zhttps://doi.org/10.1186/s13027-021-00403-1https://doaj.org/toc/1750-9378Abstract Background Human papillomavirus (HPV), primarily genotypes 6 and 11, cause the majority of cases of anogenital warts (AGW). Although benign, AGW are associated with a substantial economic and psychosocial burden. Several vaccines have been developed to prevent HPV. The objective of this study was to describe the epidemiology and healthcare resource utilization of AGW in Morocco, as well as the associated costs of treatment from the public healthcare perspective. Methods This was a descriptive analysis of questionnaire data obtained via a Delphi panel. The panel consisted of 9 physicians practicing in public hospitals in Morocco (4 dermatologists and 5 obstetricians/gynecologists). The questionnaire collected data on physician and practice characteristics, diagnostic tests and procedures, treatments, and follow-up (including recurrence) of patients with AGW. Questionnaire items on which ≥ 70% of respondents agreed were considered as having consensus. Costs associated with diagnosis, treatment, and follow-up were calculated in Moroccan dirham (MAD) and converted to euros (€) based on official national price lists for public hospitals and the HCRU estimates from the questionnaire. Results The physician-estimated prevalence of AGW in Morocco was 1.6%-2.6% in women and 2.0%-5.3% in men. A mean (median) of 6.4 (4) patients per month per physician sought medical attention for AGW. Simple observation was the most common diagnostic method for AGW in both men and women, and excision was the most prescribed therapy (75%), requiring a mean of 2 visits. Recurrence occurred in approximately 27% of patients. The cost per case of managing AGW, including recurrence, was estimated at 2182–2872 MAD (€207–272) for women and 2170–2450 MAD (€206–233) for men. The total annual cost of medical consultations for AGW in Morocco ranged from 3,271,877 MAD to 4,253,703 MAD (€310,828–404,102). Conclusions Expert consensus indicates that AGW represent a significant burden to the Moroccan public healthcare system. These data can inform policy makers regarding this vaccine-preventable disease.Myriam BerradaRyan HollTidiane NdaoGoran BenčinaSiham DikhayeAbdelilah MelhoufSoumiya ChihebKhalid GuelzimBMCarticleAnogenital wartsGenital wartsCondyloma acuminatumPapillomavirus infectionsEpidemiologyNorth AfricaNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282Infectious and parasitic diseasesRC109-216ENInfectious Agents and Cancer, Vol 16, Iss 1, Pp 1-10 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Anogenital warts Genital warts Condyloma acuminatum Papillomavirus infections Epidemiology North Africa Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Infectious and parasitic diseases RC109-216
spellingShingle	Anogenital warts Genital warts Condyloma acuminatum Papillomavirus infections Epidemiology North Africa Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Infectious and parasitic diseases RC109-216 Myriam Berrada Ryan Holl Tidiane Ndao Goran Benčina Siham Dikhaye Abdelilah Melhouf Soumiya Chiheb Khalid Guelzim Healthcare resource utilization and costs associated with anogenital warts in Morocco
description	Abstract Background Human papillomavirus (HPV), primarily genotypes 6 and 11, cause the majority of cases of anogenital warts (AGW). Although benign, AGW are associated with a substantial economic and psychosocial burden. Several vaccines have been developed to prevent HPV. The objective of this study was to describe the epidemiology and healthcare resource utilization of AGW in Morocco, as well as the associated costs of treatment from the public healthcare perspective. Methods This was a descriptive analysis of questionnaire data obtained via a Delphi panel. The panel consisted of 9 physicians practicing in public hospitals in Morocco (4 dermatologists and 5 obstetricians/gynecologists). The questionnaire collected data on physician and practice characteristics, diagnostic tests and procedures, treatments, and follow-up (including recurrence) of patients with AGW. Questionnaire items on which ≥ 70% of respondents agreed were considered as having consensus. Costs associated with diagnosis, treatment, and follow-up were calculated in Moroccan dirham (MAD) and converted to euros (€) based on official national price lists for public hospitals and the HCRU estimates from the questionnaire. Results The physician-estimated prevalence of AGW in Morocco was 1.6%-2.6% in women and 2.0%-5.3% in men. A mean (median) of 6.4 (4) patients per month per physician sought medical attention for AGW. Simple observation was the most common diagnostic method for AGW in both men and women, and excision was the most prescribed therapy (75%), requiring a mean of 2 visits. Recurrence occurred in approximately 27% of patients. The cost per case of managing AGW, including recurrence, was estimated at 2182–2872 MAD (€207–272) for women and 2170–2450 MAD (€206–233) for men. The total annual cost of medical consultations for AGW in Morocco ranged from 3,271,877 MAD to 4,253,703 MAD (€310,828–404,102). Conclusions Expert consensus indicates that AGW represent a significant burden to the Moroccan public healthcare system. These data can inform policy makers regarding this vaccine-preventable disease.
format	article
author	Myriam Berrada Ryan Holl Tidiane Ndao Goran Benčina Siham Dikhaye Abdelilah Melhouf Soumiya Chiheb Khalid Guelzim
author_facet	Myriam Berrada Ryan Holl Tidiane Ndao Goran Benčina Siham Dikhaye Abdelilah Melhouf Soumiya Chiheb Khalid Guelzim
author_sort	Myriam Berrada
title	Healthcare resource utilization and costs associated with anogenital warts in Morocco
title_short	Healthcare resource utilization and costs associated with anogenital warts in Morocco
title_full	Healthcare resource utilization and costs associated with anogenital warts in Morocco
title_fullStr	Healthcare resource utilization and costs associated with anogenital warts in Morocco
title_full_unstemmed	Healthcare resource utilization and costs associated with anogenital warts in Morocco
title_sort	healthcare resource utilization and costs associated with anogenital warts in morocco
publisher	BMC
publishDate	2021
url	https://doaj.org/article/6824c1857f884002b98fd070ff8214c6
work_keys_str_mv	AT myriamberrada healthcareresourceutilizationandcostsassociatedwithanogenitalwartsinmorocco AT ryanholl healthcareresourceutilizationandcostsassociatedwithanogenitalwartsinmorocco AT tidianendao healthcareresourceutilizationandcostsassociatedwithanogenitalwartsinmorocco AT goranbencina healthcareresourceutilizationandcostsassociatedwithanogenitalwartsinmorocco AT sihamdikhaye healthcareresourceutilizationandcostsassociatedwithanogenitalwartsinmorocco AT abdelilahmelhouf healthcareresourceutilizationandcostsassociatedwithanogenitalwartsinmorocco AT soumiyachiheb healthcareresourceutilizationandcostsassociatedwithanogenitalwartsinmorocco AT khalidguelzim healthcareresourceutilizationandcostsassociatedwithanogenitalwartsinmorocco
_version_	1718419191349903360

Healthcare resource utilization and costs associated with anogenital warts in Morocco

Ejemplares similares